Moreover, several studies showed that patients with diabetes and cardiovascular disease or at high cardiovascular risk who are treated with GLP-1 receptor agonists had a reduced risk of adverse cardiovascular events [57,58]
Semaglutide, the original weekly GLP-1 agonist, now spans injectable and oral forms and carries approvals that reach into cardiovascular risk reduction and liver disease
The 0.3 mL syringe with half-unit markings is essential at these concentrations, especially for starting doses
once the weight is there, the body puts up a surprisingly strong fight to hang on to it, driven by evolutionary forces that equate weight loss with starvation and the death of the human species
Also, an analysis by meta-analysis of controlled trials has shown that low-carb diets have a significant impact on BMI, HOMA-IR (insulin resistance), and cholesterol content, especially when interventions last more than four weeks [76]